Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Panacea Life Sciences has an established commercial portfolio of plant-derived products (CBD, CBG, kratom, kava, mushrooms) for human and veterinary wellness, with growing research into psychedelics and cannabinoids in collaboration with Colorado State University. They distribute both direct-to-consumer and via retailers, and are developing research-backed cannabinoid and mushroom products for multiple health and wellness areas[1][2][3][4].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Panacea Life Sciences.